Delivery Order SPE2DR25D2014-SPE2DR26FZ83H
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30, with a contract ceiling value of $1,210.05. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's larger Indefinite Delivery Contract (IDC) vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Ondansetron ODT (orally disintegrating tablets) 4 mg in quantities of 30 tablets. This is a firm fixed-price delivery order with a ceiling value of $4,137.90 and an ultimate completion date of December 9, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,097.78 for Ondansetron ODT 4 mg tablets (30-count supply) on November 28, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. Performance is scheduled for completion by December 1, 2025, and work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $35,990.01. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of September 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Ondansetron ODT 4 mg tablets in a quantity of 30 units, with a ceiling value of $5,449.50. This competitively awarded, firm fixed-price delivery order is set to be completed by August 21, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the open competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $9,523.13 under firm fixed pricing terms, with an ultimate completion date of November 25, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Ondansetron ODT 8 mg tablets in a 30-count package. This is a firm fixed price delivery order with a ceiling value of $3,275.55 and an ultimate completion date of October 20, 2025. The contract was competitively awarded with no set-aside designation, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Ondansetron ODT 4 mg tablets in a 30-count package. This is a firm fixed-price delivery order with a ceiling value of $6,513.17 and an ultimate completion date of November 13, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen will perform this work at its corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Ondansetron HCL 4 mg tablets in quantities of 30 units, with a contract ceiling value of $7,043.20 and an ultimate completion date of November 14, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Ondansetron ODT 8 mg tablets (30-count packaging) with a ceiling value of $1,733.90. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by December 12, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a typical transaction under the...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ83HDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count packages) with a ceiling value of $2,779.59. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the agency's pharmaceutical procurement process. The order is set for completion by December 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to military healthcare systems worldwide. Ondansetron, an antiemetic medication commonly used in military and veteran healthcare settings, exemplifies the specialized pharmaceutical products delivered through this strategic contract vehicle to support the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 11/30/25 |